MKP-1 as a novel anti-inflammatory drug target: cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1
- Lehtola, T. (Contributor)
- Nummenmaa, E. (Contributor)
- Tiina Leppänen (Contributor)
- Riina Nieminen (Contributor)
- Hämäläinen, M. (Contributor)
- Vuolteenaho, K. (Contributor)
- Eeva Moilanen (Contributor)
Aktiviteetti: Konferenssiesitelmä